Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TEAM vs MRNA✓SelectedUSD · MRNATEAM vs MRNA performance historyLatest closeAs of-4.21%11/18
Stock and ETF performance explorer

TEAM vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+67.8%
MRNA return
+794.5%
Excess return
-726.7%
Maximum drawdown
-87.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-4.2%-4.8%+0.6%-3.8%
7D-11.4%-20.9%+9.5%-9.5%
30D-37.1%-13.3%-23.8%-36.6%
3M-17.1%+212.6%-229.7%-31.9%
6M+51.0%+309.0%-258.0%+18.9%
YTD-16.7%+567.3%-584.0%-39.9%
1Y-9.2%+689.7%-698.9%-36.3%
3Y-27.0%+157.4%-184.4%-42.7%
5Y-69.4%-21.7%-47.6%-73.1%
All+67.8%+794.5%-726.7%+24.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling